BioAge Labs (BIOA) is expected to report an EPS of -0.83 for the fiscal quarter ending December 31, 2024, according to the latest forecast. This suggests that the company may continue to face challenges or incur significant expenses during the period, potentially impacting its financial performance negatively1.